Deutsche Biotech Innovativ AG
DBI | XFRA
Overview
Corporate Details
- ISIN(s):
- DE000A0Z25L1
- LEI:
- 391200BIDNL2ZOKI1M61
- Country:
- Germany
- Address:
- Neuendorfstraße 15a, 16761 Hennigsdorf
- Website:
- https://www.dbi-ag.de/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Deutsche Biotech Innovativ (DBI) AG is a listed biotechnology company based in Hennigsdorf near Berlin. The DBI share (DE000A0Z25L1) is traded over-the-counter on the Düsseldorf Stock Exchange. Since fall 2017, the DBI share has also been listed on the Frankfurt Stock Exchange and the Berlin Stock Exchange. DBI AG was founded in 2009 as Venetus Beteiligungen AG. The company was renamed Deutsche Biotech Innovativ AG in August 2014. DBI invests in biotechnology companies that pursue an innovative research and development approach and develop drug candidates with a high unique selling proposition.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2022-04-21 10:27 |
Regulatory News Service
Deutsche Biotech Innovativ AG: Paul-Ehrlich Institut-(PEI)-Zulassung fur eine d…
|
German | 33.0 KB | |
| 2021-02-04 20:01 |
Board/Management Change
Deutsche Biotech Innovativ AG: Veranderungen in Vorstand und Aufsichtsrat
|
German | 5.4 KB | |
| 2020-09-16 06:30 |
Regulatory News Service
Deutsche Biotech Innovativ AG: * Positive Ergebnisse der Phase-II-Studie Adreno…
|
German | 6.5 KB | |
| 2020-08-25 10:58 |
Regulatory News Service
Deutsche Biotech Innovativ AG: Barrier function of blood vessels as therapeutic…
|
English | 7.5 KB | |
| 2020-08-19 14:00 |
Regulatory News Service
Deutsche Biotech Innovativ AG: Further step towards a strong capital market ori…
|
English | 7.6 KB | |
| 2020-08-19 09:15 |
Regulatory News Service
Deutsche Biotech Innovativ AG: Erste Investition in das Biomarker-Unternehmen S…
|
German | 7.6 KB | |
| 2020-07-21 10:00 |
Regulatory News Service
Deutsche Biotech Innovativ AG: Shares admitted to Xetra trading, Baader Bank AG…
|
English | 6.2 KB | |
| 2020-06-04 10:00 |
Board/Management Change
Deutsche Biotech Innovativ AG: Ralf M. Jakobs neuer CFO der DBI AG
|
German | 6.6 KB | |
| 2020-02-25 11:07 |
Regulatory News Service
Deutsche Biotech Innovativ AG: Beteiligungsunternehmen AdrenoMed AG verkundet…
|
German | 6.4 KB | |
| 2020-02-21 14:02 |
Earnings Release
Bekanntgabe von positiven Ergebnissen der klinischen Phase II Studie AdrenOSS-2…
|
German | 4.5 KB | |
| 2019-09-30 13:30 |
Board/Management Change
Deutsche Biotech Innovativ AG: Beteiligungsunternehmen AdrenoMed AG
|
German | 8.5 KB | |
| 2019-03-22 12:30 |
Regulatory News Service
Deutsche Biotech Innovativ AG: Beteiligungsunternehmen AdrenoMed AG veroffentli…
|
German | 8.3 KB | |
| 2018-11-23 19:30 |
Regulatory News Service
- Kapitalerhohung bei Tochtergesellschaft AdrenoMed AG: Mittelzufluss von rd. …
|
German | 5.4 KB | |
| 2018-07-10 09:30 |
Regulatory News Service
DBI AG mit Zweitlisting in Frankfurt; DBI Wechsel im Aufsichtsrat; Adrenomed: W…
|
German | 10.5 KB | |
| 2017-08-16 17:04 |
Share Issue/Capital Change
Deutsche Biotech Innovativ AG: Kapitalerhohung
|
German | 7.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ANIMALCARE GROUP PLC | United Kingdom | ANCR | |
|
Annexin Pharmaceuticals AB | Sweden | ANNX | |
|
Apontis Pharma AG | Germany | APPH | |
|
Aptahem AB | Sweden | APTA | |
|
Arctic Bioscience | Norway | ABS | |
|
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
|
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
|
AroCell AB | Sweden | AROC | |
|
Arterra Bioscience | Italy | ABS |